Xcell Biosciences announced today the company has closed a $12 million Series A private equity financing round. The financing was led by HBM Genomics along with the continued participation of all ...
Xcell Biosciences announced today that it has expanded its development and commercial efforts around new market opportunities in immunotherapy drug research and development. The ever-growing ...
Two-wheel vehicles are now changing and evolving perhaps faster than ever before, with ambitious startups all over the world ready to shake things up with disruptive designs and technologies. One of ...
In recent years, fed-batch biomanufacturing has begun giving way to continuous manufacturing processes, as developers face pressure to balance affordability with high manufacturing quality. Although ...
LAUSANNE, Switzerland--(BUSINESS WIRE)--NewBiologix, a technology innovation company pioneering innovative tools enabling efficient, cost-effective, and large-scale production of viral vectors for ...
LAUSANNE, Switzerland and BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- NewBiologix, a technology innovation company enabling efficient, cost-effective, and scalable production of viral vectors for cell ...
SAN FRANCISCO, June 24, 2025 – Xcell Biosciences (Xcellbio), a San Francisco-based instrumentation company focused on cell and gene therapy applications, today announced a strategic collaboration with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback